Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Department of Anesthesiology and Intensive CareMedicine, Charité Campus Benjamin Franklin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Department of Anesthesiology and Intensive CareMedicine, Charité Campus Benjamin Franklin, Berlin, Germany.
J Cardiothorac Vasc Anesth. 2023 Jan;37(1):50-57. doi: 10.1053/j.jvca.2022.10.001. Epub 2022 Oct 9.
The objective of the study was to compare the overall feasibility, respiratory and hemodynamic stability, as well as process times of a dexmedetomidine-based sedative regimen compared with general anesthesia among patients undergoing MitraClip procedures.
A retrospective cohort study.
A single tertiary care university center.
The study included 79 patients.
Dexmedetomidine sedation versus general anesthesia.
Seventy-nine MitraClip procedures in dexmedetomidine/remifentanil conscious sedation (DCS, n = 26) or general anesthesia (GA, n = 53), performed between 2018 and 2020 at Charité - Universitätsmedizin Berlin, were analyzed retrospectively. Patients' median age was 81 years in both groups without differences in preinterventional EuroScore I (DCS 6 [5; 8], GA 7 [6; 8]) or systolic function (left ventricular ejection fraction: DCS 50% [32; 60] v. GA 50% [36; 60]; tricuspid annular plane systolic excursion: DCS 19 mm [16; 22] v GA 19 mm [15; 22]). During MitraClip procedures, respiratory parameters revealed no differences between groups, whereas patients under DCS showed higher mean arterial pressures (DCS 64 mmHg [59; 74] v GA 58 mmHg [53; 66]) and needed less norepinephrine (DCS 0.0µg/kg/min [0.0; 0.2] v GA 0.08 µg/kg/min [0.05; 0.15]). Emergence from both anesthesia regimens to readiness for intensive care unit transfer was faster in DCS (8 min [4; 18] v GA 16 min [11; 23]); however, total process time was comparable between groups (DCS 128 min [104; 155] v GA 142 min [117; 190]). Two patients required a switch from DCS to GA due to oral bleeding or prolonged procedure time. Both were excluded from the analysis. There was no switch to open surgery and no differences in postoperative complications between DCS and GA.
Dexmedetomidine/remifentanil sedation appears to be feasible and a safe option for MitraClip procedures, and provides better hemodynamic stability with faster emergence times compared with general anesthesia.
本研究旨在比较右美托咪定镇静方案与全身麻醉在二尖瓣夹合术(MitraClip)患者中的总体可行性、呼吸和血液动力学稳定性以及手术时间。
回顾性队列研究。
一家单一的三级护理大学中心。
研究纳入了 79 例患者。
右美托咪定镇静与全身麻醉。
2018 年至 2020 年期间,在柏林 Charité - Universitätsmedizin 进行了 79 例右美托咪定/瑞芬太尼清醒镇静(DCS,n=26)或全身麻醉(GA,n=53)的 MitraClip 手术,进行了回顾性分析。两组患者的中位年龄均为 81 岁,介入前的 EuroScore I 无差异(DCS 6[5;8],GA 7[6;8])或收缩功能(二尖瓣环平面收缩期位移:DCS 50%[32;60]v.GA 50%[36;60];三尖瓣环平面收缩期位移:DCS 19mm[16;22]v.GA 19mm[15;22])。在 MitraClip 手术过程中,两组患者的呼吸参数无差异,而 DCS 组的平均动脉压较高(DCS 64mmHg[59;74]v.GA 58mmHg[53;66]),需要的去甲肾上腺素较少(DCS 0.0μg/kg/min[0.0;0.2]v.GA 0.08μg/kg/min[0.05;0.15])。DCS 组从麻醉中苏醒至准备转入重症监护病房的时间更快(8min[4;18]v.GA 16min[11;23]);然而,两组的总手术时间相当(DCS 128min[104;155]v.GA 142min[117;190])。由于口腔出血或手术时间延长,有 2 例患者需要从 DCS 切换至 GA。这 2 例患者均被排除在分析之外。没有切换到开放手术,DCS 和 GA 之间的术后并发症无差异。
与全身麻醉相比,右美托咪定/瑞芬太尼镇静似乎是二尖瓣夹合术可行且安全的选择,具有更好的血液动力学稳定性,苏醒时间更快。